CN220026711U - Nafamostat mesylate preparation tank for injection - Google Patents
Nafamostat mesylate preparation tank for injection Download PDFInfo
- Publication number
- CN220026711U CN220026711U CN202321054365.3U CN202321054365U CN220026711U CN 220026711 U CN220026711 U CN 220026711U CN 202321054365 U CN202321054365 U CN 202321054365U CN 220026711 U CN220026711 U CN 220026711U
- Authority
- CN
- China
- Prior art keywords
- device main
- injection
- nafamostat mesylate
- filter
- preparation tank
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MQQNFDZXWVTQEH-UHFFFAOYSA-N nafamostat Chemical compound C1=CC(N=C(N)N)=CC=C1C(=O)OC1=CC=C(C=C(C=C2)C(N)=N)C2=C1 MQQNFDZXWVTQEH-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 229950009865 nafamostat Drugs 0.000 title claims abstract description 35
- 238000002347 injection Methods 0.000 title claims abstract description 34
- 239000007924 injection Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 4
- 239000011550 stock solution Substances 0.000 abstract description 26
- 238000003756 stirring Methods 0.000 abstract description 9
- 239000012535 impurity Substances 0.000 abstract description 7
- 238000009413 insulation Methods 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 description 11
- 238000001914 filtration Methods 0.000 description 4
- 108010088842 Fibrinolysin Proteins 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Accessories For Mixers (AREA)
Abstract
The utility model discloses a preparation tank of nafamostat mesylate for injection, which relates to the technical field of nafamostat mesylate preparation and comprises a device main body, a top cover, wheels and handrails, wherein the top of the device main body is provided with the top cover, the top of the top cover is provided with a feed pipe, the middle of the feed pipe is connected with a flow valve, the top of the flow valve is provided with a flow meter, the top of the right side of the feed pipe is provided with a filter opening, the top of the top cover is provided with a motor, the motor passes through the top cover to be connected with a rotating shaft, the outer side of the rotating shaft is provided with a stirring rod, a cavity is formed in the device main body, and the bottom of the inner side of the device main body is provided with an insulation board. Due to the reasons of the filter port and the filter valve, the stock solution of the nafamostat mesylate for injection can be filtered once when entering the cavity through the filter port, and can be filtered once again by the filter valve when passing the discharge port, so that impurities in the stock solution of the nafamostat mesylate for injection can be strictly filtered by the two filter systems, and the impurities in the nafamostat mesylate for injection are reduced.
Description
Technical Field
The utility model relates to the technical field of nafamostat mesylate preparation, in particular to a nafamostat mesylate preparation tank for injection.
Background
The nafamostat mesylate for injection has strong selective inhibition effect on trypsin-like serine proteinase such as trypsin, kallikrein, plasmin, fibrinolysin, CL-r, CL-s of the classical pathway of the complement system and the like; the injection has the effects of inhibiting phospholipase A2 and trypsin combined with alpha 2-macroglobulin in vitro, and when the nafamostat mesylate for injection is stored, a professional preparation device is needed to store some medicines because the stock solution of the medicine is more noble;
however, the existing devices for preparing nafamostat mesylate for injection on the market have a plurality of defects, such as that when stock solution or raw material of nafamostat mesylate for injection is stored, precipitation of substances in the stock solution is likely to occur, so that the nafamostat mesylate for injection is troublesome in preparation, and is stored in an overcooled or overheated environment, and some materials are likely to be damaged due to temperature, so that unnecessary waste is caused.
We have therefore proposed a nafamostat mesylate preparation tank for injection in order to solve the problems set forth above.
Disclosure of Invention
The utility model aims to provide a nafamostat mesylate preparation tank for injection, which aims to solve the problems that substances in liquid are easy to precipitate and materials are damaged due to temperature in the preparation tank proposed by the background art.
In order to achieve the above purpose, the present utility model provides the following technical solutions: the utility model provides a methanesulfonic acid nafamostat preparation jar for injection, including device main part, top cap, wheel and handrail, device main part top is equipped with the top cap, and the top cap top is equipped with the inlet pipe, and inlet pipe intermediate junction flow valve, and flow valve top is equipped with the flowmeter, and inlet pipe right side top is equipped with the straining port, the top cap top is equipped with the motor, and the motor passes the top cap and is connected with the rotation axis, and the rotation axis outside is equipped with the puddler, device main part inside is equipped with the cavity, and device main part inboard bottom is equipped with the heated board, and device main part bottom left side is equipped with the discharge gate, and the discharge gate passes the device main part and is connected with the straining valve.
Due to the reasons of the filter port and the filter valve, the nafamostat mesylate stock solution for injection can be filtered once when entering the cavity through the filter port, and can be filtered once again through the filter valve when passing through the discharge port, so that impurities in the nafamostat mesylate stock solution for injection can be tightly filtered by two filter systems, the impurities in the nafamostat mesylate for injection are reduced, and when the nafamostat mesylate stock solution for injection is stored for a long time through the equipment such as a rotating shaft, a stirring rod and the like, a user can start the device, the internal deposition is reduced, and the use of the stock solution is ensured.
As a preferable embodiment of the present utility model, a bottom plate is provided at the bottom of the device main body, and the bottom plate is connected to the device main body by bolts.
By adopting the technical scheme, the device body can be connected with the bottom plate more firmly, and the device can be easily disassembled.
As a preferable technical scheme of the utility model, the bottom of the bottom plate is provided with a plurality of wheels, and the top of the right side of the bottom plate is provided with a handrail.
By adopting the technical scheme, when a user wants to move the device, the device is quite convenient, and the transportation performance is improved.
As a preferable technical scheme of the utility model, the discharging port is in threaded connection with the filter valve.
By adopting the technical scheme, when a user cleans the device, the filter valve can be unscrewed to clean the filter screen inside.
As the preferable technical scheme of the utility model, the outer side of the top cover is provided with a plurality of buckles, the top cover is connected with the device main body by the buckles, and the bottom of the filter opening is provided with a layer of filter screen.
By adopting the technical scheme, when the stock solution passes through the filtering port, a part of impurities can be filtered by the filter screen, so that the stock solution becomes purer.
As the preferable technical scheme of the utility model, the top of the bottom plate is provided with a support, and the support is connected with the feeding pipe.
By adopting the technical scheme, the feeding pipe and the equipment connected with the feeding pipe are provided with a fixed supporting point, so that the overall stability of the device is improved.
Compared with the prior art, the utility model has the beneficial effects that:
1. due to the reasons of the filter port and the filter valve, the nafamostat mesylate stock solution for injection can be filtered once when entering the cavity through the filter port, and can be filtered once again by the filter valve when passing through the discharge port, so that impurities in the nafamostat mesylate stock solution for injection can be tightly filtered by two filter systems, the impurities in the nafamostat mesylate for injection are reduced, and when the nafamostat stock solution for injection is stored for a long time through the equipment such as a rotating shaft, a stirring rod and the like, a user can start the device, so that the internal deposition is reduced, and the use of the stock solution is ensured;
2. through the heated board, make injection use methanesulfonic acid nafamostat stoste to deposit under extreme environment, the device main part also can guarantee its certain temperature to reduce the damage of injection use methanesulfonic acid nafamostat stoste, and through equipment such as wheel and handrail, make the user can become more light when removing the device, thereby reduced transportation cost.
Drawings
FIG. 1 is a schematic cross-sectional elevation view of the present utility model;
FIG. 2 is a schematic top view of the device body of the present utility model;
FIG. 3 is a schematic elevational view of the present utility model;
FIG. 4 is a schematic top view of the present utility model;
fig. 5 is an enlarged schematic view of the structure of fig. 1 a according to the present utility model.
In the figure: 1. a device body; 2. a top cover; 3. a support; 4. filtering; 5. a feed pipe; 6. a flow valve; 7. a flow meter; 8. a motor; 9. a rotation shaft; 10. a stirring rod; 11. a cavity; 12. a thermal insulation board; 13. a discharge port; 14. a filter valve; 15. a bottom plate; 16. a wheel; 17. an armrest.
Detailed Description
The following description of the embodiments of the present utility model will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present utility model, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.
Referring to fig. 1-5, the present utility model provides a technical solution: the nafamostat preparation tank for injection comprises a device main body 1, a top cover 2, wheels 16 and handrails 17, wherein the top of the device main body 1 is provided with the top cover 2, the top of the top cover 2 is provided with a feed pipe 5, a flow valve 6 is linked in the middle of the feed pipe 5, the top of the flow valve 6 is provided with a flow meter 7, the top of the right side of the feed pipe 5 is provided with a filter port 4, the top of the top cover 2 is provided with a motor 8, the motor 8 penetrates through the top cover 2 to be connected with a rotating shaft 9, the outer side of the rotating shaft 9 is provided with a stirring rod 10, a cavity 11 is arranged in the device main body 1, the bottom of the inner side of the device main body 1 is provided with a heat insulation plate 12, the left side of the bottom of the device main body 1 is provided with a discharge port 13, and the discharge port 13 penetrates through the device main body 1 to be connected with a filter valve 14; pouring the stock solution from the filter port 4, filtering the stock solution for the first time by a filter screen in the filter port 4, opening a flow valve 6, observing the dosage of the stock solution by a flowmeter 7, allowing the stock solution to enter a cavity 11 along a feed pipe 5, starting a motor 8 to drive a rotating shaft 9 to rotate, and simultaneously, connecting the rotating shaft 9 with a stirring rod 10, and rotating the stirring rod 10, so that the stock solution in the cavity 11 is prevented from precipitating, a heat-insulating plate 12 keeps the stock solution in the cavity 11 for a certain time, the stock solution is prevented from being influenced by external temperature, and when a user wants to use the stock solution, the user only needs to open a filter valve 14 to enable the stock solution to flow from a discharge port 13 to the filter valve 14, and then the stock solution is filtered again by the filter valve 14 to enable the stock solution to be filtered for the second time;
the bottom of the device main body 1 is provided with a bottom plate 15, and the bottom plate 15 is connected with the device main body 1 by bolts; the bottom of the bottom plate 15 is provided with a plurality of wheels 16, and the top of the right side of the bottom plate 15 is provided with a handrail 17; the discharge hole 13 is in threaded connection with the filter valve 14, a plurality of buckles are arranged on the outer side of the top cover 2, the top cover 2 is in buckled connection with the device main body 1, and a layer of filter screen is arranged at the bottom of the filter hole 4; the top of the bottom plate 15 is provided with a support 3, and the support 3 is connected with the feeding pipe 5; when a user wants to clean the device, the user only needs to detach the flow valve 6 and then open the buckle on the top cover 2, so that the cavity 11 and other devices in the device main body 1 can be cleaned, and when the filter valve 14 is replaced, the user only needs to unscrew the filter valve 14 to clean.
Working principle: when the nafamostat mesylate preparation tank for injection is used, raw liquid is poured from the filter port 4, a filter screen in the filter port 4 is used for carrying out primary filtration on the raw liquid, then the flow valve 6 is opened, the flow meter 7 is used for observing the consumption of the raw liquid, the raw liquid enters the cavity 11 along the feed pipe 5, then the motor 8 is started, the motor 8 drives the rotating shaft 9 to rotate, meanwhile, the rotating shaft 9 is connected with the stirring rod 10, the stirring rod 10 also rotates along with the rotating shaft, so that the raw liquid in the cavity 11 is prevented from precipitating, the heat-insulating plate 12 is used for carrying out certain heat insulation on the raw liquid in the cavity 11, the raw liquid is prevented from being influenced by external temperature, when a user wants to use the raw liquid, the raw liquid is filtered again by opening the filter valve 14, and the raw liquid is filtered again by the filter valve 14 from the discharge port 13;
when a user wants to clean the device, the user only needs to detach the flow valve 6 and then open the buckle on the top cover 2, so that the cavity 11 and other devices in the device main body 1 can be cleaned, and when the filter valve 14 is replaced, the user only needs to unscrew the filter valve 14 to clean.
To complete a series of work, and what is not described in detail in this specification is prior art that is well known to those skilled in the art.
Although the present utility model has been described with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments described, or equivalents may be substituted for elements thereof, and any modifications, equivalents, improvements and changes may be made without departing from the spirit and principles of the present utility model.
Claims (6)
1. The utility model provides a methanesulfonic acid nafamostat preparation tank for injection, includes device main part (1), top cap (2), wheel (16) and handrail (17), its characterized in that: device main part (1) top is equipped with top cap (2), and top cap (2) top is equipped with inlet pipe (5), and inlet pipe (5) intermediate junction flow valve (6), and flow valve (6) top is equipped with flowmeter (7), and inlet pipe (5) right side top is equipped with straining mouthful (4), top cap (2) top is equipped with motor (8), and motor (8) pass top cap (2) and rotation axis (9) and be connected, and rotation axis (9) outside is equipped with puddler (10), device main part (1) inside is equipped with cavity (11), and device main part (1) inboard bottom is equipped with heated board (12), and device main part (1) bottom left side is equipped with discharge gate (13), and discharge gate (13) pass device main part (1) and are connected with filter valve (14).
2. The nafamostat mesylate preparation tank for injection according to claim 1, characterized in that: the bottom of the device main body (1) is provided with a bottom plate (15), and the bottom plate (15) is connected with the device main body (1) through bolts.
3. The nafamostat mesylate preparation tank for injection according to claim 2, characterized in that: the bottom of the bottom plate (15) is provided with a plurality of wheels (16), and the top of the right side of the bottom plate (15) is provided with a handrail (17).
4. The nafamostat mesylate preparation tank for injection according to claim 1, characterized in that: the discharge hole (13) and the filter valve (14) form threaded connection.
5. The nafamostat mesylate preparation tank for injection according to claim 1, characterized in that: the top cover (2) outside is equipped with the buckle of several, and top cover (2) and device main part (1) constitute the buckle and are connected to strain mouth (4) bottom and be equipped with one deck filter screen.
6. The nafamostat mesylate preparation tank for injection according to claim 2, characterized in that: the top of the bottom plate (15) is provided with a support (3), and the support (3) is connected with the feeding pipe (5).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202321054365.3U CN220026711U (en) | 2023-05-05 | 2023-05-05 | Nafamostat mesylate preparation tank for injection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202321054365.3U CN220026711U (en) | 2023-05-05 | 2023-05-05 | Nafamostat mesylate preparation tank for injection |
Publications (1)
Publication Number | Publication Date |
---|---|
CN220026711U true CN220026711U (en) | 2023-11-17 |
Family
ID=88744372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202321054365.3U Active CN220026711U (en) | 2023-05-05 | 2023-05-05 | Nafamostat mesylate preparation tank for injection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN220026711U (en) |
-
2023
- 2023-05-05 CN CN202321054365.3U patent/CN220026711U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN207987173U (en) | A kind of fermentation tank equipped with air filter | |
CN220026711U (en) | Nafamostat mesylate preparation tank for injection | |
CN109678286A (en) | A kind of water purification system and water dispenser | |
CN206603048U (en) | A kind of full-automatic ecological fish bowl for changing water | |
CN219815551U (en) | Filter with double filtering channels | |
CN205710137U (en) | Wastewater treatment equipment | |
CN207175912U (en) | A kind of Filtration of Yellow Rice Wine device | |
CN215691758U (en) | Rectifying device is used in acetylacetone production | |
CN209322644U (en) | A kind of water purification system and water dispenser | |
CN206285705U (en) | A kind of exhaust gas treating device of epitaxy technique | |
CN211659392U (en) | Novel magnesium chloride separation device | |
CN209646249U (en) | Ultra-filtration membrane device | |
CN208561927U (en) | A kind of novel micro- waste water water purifier | |
CN211198907U (en) | Prevent inside sewage treatment ware that deposits jam | |
CN208920719U (en) | A kind of rutin sodium prepares drying device | |
CN208115320U (en) | A kind of sewage disposal device | |
CN218357759U (en) | Raw material impurity removing device for pranoprofen preparation | |
CN212955356U (en) | Metal treatment mechanical filtration type tri-acidification polishing tank | |
CN105540821B (en) | A kind of slow filter processing system of hybrid biology of stop-off | |
CN220878075U (en) | Lithium carbonate processing purifying tank convenient for precipitation treatment | |
CN220834310U (en) | Honey edulcoration equipment | |
CN211595472U (en) | Bromfenac sodium intermediate purification system | |
CN218262070U (en) | Reverse osmosis unit filtration | |
CN214820723U (en) | Double screw extruder feed arrangement is used in PVB membrane production | |
CN216260231U (en) | A transfer fluid reservoir for production of polycrystal crystal sugar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |